[ad_1] NESS ZIONA, Israel, November 12, 2018 /PRNewswire/ — Israeli biotechnology company Kadimastem (TASE: KDST) announces the approval by the European Union and the Israel Innovation Authority, to receive a joint research …
Read More »Kadimastem and Defymed Awarded Grant in the EU’s Prestigious Eurostars Program for the Clinical Development of an Integrated Product for the Treatment of Diabetes
